If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 101 - 110 of 270
Behavioral Assessment of Semantic Representation Data
Objective
Behavioral Assessment of Semantic Representation Data
Protocol No
NEURO-IIT-LF-BASR
Examination of Motor Unit Alterations in Acute and Subacute Stroke
Objective
Motor Unit Alterations in Acute and Subacute Stroke
Protocol No
NEURO-IIT-LI-MOTOR-UNIT-ALT
Categories
A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia
Objective
HD-tDCS for Phonological Impairment in Aphasia
Protocol No
NEURO-IIT-PILLAY-ALF-TDCS
Behavioral Aphasia Treatments
Objective
Behavioral Aphasia Treatments
Protocol No
NEURO-IIT-PSB-BAT
Categories
TES To Remediate Phonological Impairments After Stroke
Objective
TES for Language Impairment
Protocol No
NEURO-IIT-SHAH-TES
Categories
Gut-oral-microbiota-brain Axis in Adults at Risk for AD
Objective
SCD Microbiome Project
Protocol No
NEURO-IIT-UMFLEET-SCDMICROB
Anticoagulation in Intracerebral Hemorrhage Survivors for Stroke Prevention and Recovery
Objective
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (ASPIRE)
Protocol No
NEURO-NINDS-ASPIRE
Categories
Statin Use in Intracerebral Hemorrhage Patients
Objective
Statins In Intracerbral Hemorrhage (SATURN)
Protocol No
NEURO-NINDS-SATURN
Categories
Parkinson's Foundation PD GENEration Genetic Registry
Objective
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE
Master Protocol of Two Independent, Randomized, Double-Blind, Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants with Relapsing Forms of Multiple Sclerosis
Objective
Master Protocol for SAR441344 to Teriflunomide in Relapsing MS
Protocol No
NEURO-SANOFI-EFC17919